Navigation Links
Medical Scientist Discovers an Alternative Treatment for Leukemia Using Alkaline Ionized or Electrolyzed Reduced Drinking Water
Date:4/26/2013

Boca Raton (PRWEB) April 26, 2013

The scientific study on using Electrolyzed-reduced water (ERW) to treat Leukemia Cancer cells was reviewed in the report published today by Bawell Health Water. All the different models of water ionizers that Bawell offers can produce the Electrolzyed-reduced water that was used in the PubMed scientific study. The study of using alkaline water in treating Cancer cells, reports “These results suggest that ERW is an antioxidant” (US National Library of Medicine).

The Bawell report that was published today explains how alkaline ionized water works to fight against Cancer in a variety of different ways. Alkaline ionized water has a high redox potential, which means the ORP or Oxidation Reduction Potential is very negative, making the water a good antioxidant to fight against free radicals. Today’s report explains that ionized water gives the cancer cells electrons, which causes the oxygen molecules that already exist in the body to become more available to the cancer cells. This additional oxygen will cause the growth of the cancer cell to slow down, or it can cause the cancer cell to totally die. Hydroxyl ions that are in the ionized water carry out this process.

This current PubMed study confirms the research and studies conducted by the 1931 nobel prize winner Otto Warburg. Bawell’s report says Warburg found cancer cells maintain a pH that is as low as 6.0, and Warburg believed that there was a direct relationship between oxygen and pH. There are a higher concentration of oxygen molecules when pH is higher, and when pH is lower there are lower concentrations of oxygen molecules. "Summarized in a few words, the prime cause of cancer is the replacement of the respiration of oxygen in normal body cells by a fermentation of sugar" (Otto H. Warburg).

Bawell also reviewed the Cancer research by Dr. Keiichi Morishita. Quoting the Dr. in his book "The Hidden Truth of Cancer" where it states when blood develops an acidic condition the waste is deposited throughout the body, and after years the body continues to become more acidic finally causing cell death. To survive, the cells in the acidic area of the body become abnormal or malignant, and no longer respond to brain commands. The malignant cells that are now not under the control of the brain begin to undergo cell division, which is called Cancer.

The Bawell report continues by saying, “Dr. Morishita explains that treating malignant cells with chemotherapy, radiation, or surgery as if they were a virus or bacteria does not take into account the underlying cause of the Cancer, the acidic environment. The de-acidifying effect is why drinking water that has a high alkaline pH will help in preventing cancer. In Asia, alkaline water is considered a regular part of treatment and regularly given to patients.”

The different water ionizer models that Bawell offers can produce a range of pH alkaline water, so clients can make their own ionized water at home with the exact pH required to target specific needs. The Bawell water ionizer company has been in the business of manufacturing this equipment for the past 10 years. With over 1,000,000 customers worldwide Bawell has become the most trusted internationally recognized name in the alkaline water ionizer industry. Discover more about them by visiting http://www.bawellwaterionizers.com/aboutus.html.

Read the full story at http://www.prweb.com/releases/alkaline-water-ionizer/anti-cancer-research/prweb10674364.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dedication to the Medical Industry - The First International PEEK Meeting
2. Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc.
3. VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
4. Technical Workshops at OrthoTec 2013 Focus on Risk Management Throughout Medical Device Lifecycle and Robust Material Selection Process Development
5. AFcell Medical Hires Chief Operating Officer
6. OHK Medical Devices appoints Mr. Omer Inbar as Chief Executive Officer
7. Maryville, Tennessee Based Molecular Pathology Laboratory Network (MPLN) Celebrates 38th Annual Medical Laboratory Professional Week by Honoring Employees
8. Nebraska Medical Center Implants States First SynCardia Total Artificial Heart
9. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
10. BioClinica Releases Integrated Medical Image Management Solution
11. Surefire Medical Launches Next Generation Infusion System ST-LT and Specialty Catheters at SIR - Maximizing Targeted Delivery of Embolics Without Reflux
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... NextSteps ... and North America this May on the following dates: , ?    London, ... Taylor, Chairman of the Learning and Performance Institute will be the opening ...
(Date:4/26/2017)... , April 26, 2017  Genisphere LLC, ... platform, has signed a collaborative and sponsored research ... Silvia Muro . The overall goal of ... pharmacodynamics of various 3DNA designs and formulations after ... targeting diseases of the vasculature as well as ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... supplier of Common Lisp (CL) development tools, and market leader for Semantic ... key performance enhancements now available within the most effective system for developing and ...
(Date:4/25/2017)... , April 25, 2017 ... has licensed its novel immune-modulating technology to an undisclosed ... and allergy. Tregitopes, pronounced T·rej·itopes, are ... immunoglobulin by EpiVax CEO Annie De Groot ... intravenous immunoglobulin G, an autoimmune disease therapy, Tregitopes ...
Breaking Biology Technology:
(Date:4/6/2017)... , April 6, 2017 Forecasts ... ANPR, Document Readers, by End-Use (Transportation & Logistics, Government ... Oil, Gas & Fossil Generation Facility, Nuclear Power), Industrial, ... Other) Are you looking for a definitive ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
Breaking Biology News(10 mins):